Transdermal nicotine effects on attention
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338
“rons, ADHD patients have a high rate of smoking [131] and nicotine administration reduces ADHD symptoms [132].”
BackgroundGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“1996b) and normal young adults (Levin et al. 1998), administered with a low-dose 7-mg patch for a single morning session, show significant improvement in attentional performance with only a few instances of short-term (a few hours) nausea, headache, and dizziness.”
BackgroundSelf-citationModes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD
Molina, B. S. G., & Pelham, W. E. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.497 · Cited by 706
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Functional and Neural Mechanisms of Interval Timing
(2003) · CRC Press eBooks · doi:10.1201/9780203009574 · Cited by 523
Rezvani, A. H., & Levin, E. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01094-5 · Cited by 495
Self-citationPathophysiological distortions in time perception and timed performance
Allman, M. J., & Meck, W. H. (2012) · Brain · doi:10.1093/brain/awr210 · Cited by 460
Self-citationCys-loop receptors: new twists and turns
LESTER, H. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.002 · Cited by 438
The neurocircuitry of addiction: an overview
Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421
Neuropsychology of timing and time perception
Meck, W. H. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2004.09.004 · Cited by 359
Self-citationSmoking and structural brain deficits: a volumetric MR investigation
Gallinat, J., Meisenzahl, E., Jacobsen, L. K., Kalus, P., Bierbrauer, J., Kienast, T., Witthaus, H., Leopold, K., Seifert, F., Schubert, F., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05050.x · Cited by 330
Leonard, S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C., Gault, J., Lee, M. J., Logel, J., Olincy, A., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00677-3 · Cited by 300
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Nicotine and the adolescent brain: insights from an animal model
Slotkin, T. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00199-x · Cited by 284
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
“, 2003) is consistent with historical studies showing that nicotine improves sustained attention in dnormalT humans assessed in the continuous performance test (Levin et al., 1998).”
BackgroundResultTrauth, J. A., Seidler, F. J., McCook, E. C., & Slotkin, T. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01994-0 · Cited by 230
Hahn, B., Shoaib, M., & Stolerman, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1005-6 · Cited by 188
Neuromodulation by acetylcholine: examples from schizophrenia and depression
Higley, M. J., & Picciotto, M. R. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.06.004 · Cited by 184
“Nicotinic stimulation produces well known enhancements of attention and working memory [37,38]; however, nAChR agonists have yielded mixed results in clinical trials, and pharmacotherapies directed at nicotinic signaling remain an area of active research [39].”
Thiel, C. M., Zilles, K., & Fink, G. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300633 · Cited by 182
Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors
McKay, B. E., Placzek, A. N., & Dani, J. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.001 · Cited by 181
Biological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176
SULLIVAN, M. A., & RUDNIK‐LEVIN, F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05783.x · Cited by 172
TERCYAK, K. P., LERMAN, C., & AUDRAIN, J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200207000-00011 · Cited by 162
Howe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., & Sarter, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.9 · Cited by 150
The Nicotinic Acetylcholine Receptor 5 Subunit Plays a Key Role in Attention Circuitry and Accuracy
Bailey, C. D. C., De Biasi, M., Fletcher, P. J., & Lambe, E. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-10.2010 · Cited by 146
Dose-Related Enhancement of Mood and Cognition in Smokers Administered Nicotine Nasal Spray
Myers, C. S., Taylor, R. C., Moolchan, E. T., & Heishman, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301425 · Cited by 143
Attentional effects of nicotinic agonists in rats
Hahn, B., Sharples, C. G. V., Wonnacott, S., Shoaib, M., & Stolerman, I. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00099-6 · Cited by 135
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training
Gould, T. J., & Stephen Higgins, J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00057-1 · Cited by 123
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
Semenova, S., Stolerman, I. P., & Markou, A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.009 · Cited by 104
Dawkins, L., Powell, J. H., West, R., Powell, J., & Pickering, A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0634-6 · Cited by 85
“In non-smokers, Levin et al. (1998) found nicotine to reduce the frequency of omission errors on the CPT without any increase in commission errors.”
Vossel, S., Thiel, C. M., & Fink, G. R. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301469 · Cited by 81
Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.002 · Cited by 78
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69
Chassin, L., Hussong, A., & Beltran, I. (2009) · Handbook of Adolescent Psychology · doi:10.1002/9780470479193.adlpsy001022 · Cited by 67
Nicotinic modulation of glutamatergic synaptic transmission in region CA3 of the hippocampus
Giocomo, L. M., & Hasselmo, M. E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04316.x · Cited by 52
Rezvani, A. H., Cauley, M., Sexton, H., Xiao, Y., Brown, M. L., Paige, M. A., McDowell, B. E., Kellar, K. J., & Levin, E. D. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2161-8 · Cited by 50
Self-citationMcClernon, F. J., Fuemmeler, B., Kollins, S., Kail, M., & Ashley-Koch, A. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200701704913 · Cited by 50
Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders
Arnold, L. E., Aman, M. G., Hollway, J., Hurt, E., Bates, B., Li, X., Farmer, C., Anand, R., Thompson, S., Ramadan, Y., et al. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0056 · Cited by 42
“198 Levin et al. 1998), learning (Levin 2002), anxiety (Picciotto et al. 2002), and pain perception (Marubio and Changeux 2000), which may all be relevant in autism.”
BackgroundContini, V., Rovaris, D. L., Victor, M. M., Grevet, E. H., Rohde, L. A., & Bau, C. H. D. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.006 · Cited by 34
Effect of Nonnicotine Pharmacotherapy on Smoking Behavior
Kotlyar, M., Golding, M., Hatsukami, D. K., & Jamerson, B. D. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.20.1530.34477 · Cited by 32
Acheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26
Heightened Nicotinic Regulation of Auditory Cortex during Adolescence
Kawai, H. D., Kang, H.-A., & Metherate, R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1705-11.2011 · Cited by 25
“…in adults (Wesnes and Warburton, 1983; Levin, 2002; Picciotto, 2003; Sacco et al., 2004), including auditory-cognitive functions such as attention, even in nonsmokers (Provost and Woodward, 1991; Le Houezec et al., 1994) (but see Foulds et al., 1996; Levin et al., 1998; Vossel et al., 2008).”
Metadata
- Authors
- Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J., & Rose, J. E.
- Venue
- Psychopharmacology
- Published
- 1998-11-16
- Volume
- 140
- Issue
- 2
- Pages
- 135-141
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2010375213
- Cited by
- 331
- References
- 0
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.